The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Katyna Borroto-Esoda

Gilead Sciences

Inc., Foster City

USA

[email]@gilead.com

Name/email consistency: high

[Claim this account]

Affiliations

Gilead Sciences, Inc., Foster City, USA. 2007
Gilead Sciences, Inc., 4611 University Drive, Durham, USA. 2004 - 2007
Department of Clinical Virology, Gilead Sciences, Inc., Foster City, USA. 2006

References

A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine. Borroto-Esoda, K., Parkin, N., Miller, M.D. Antivir. Chem. Chemother. (2007) [Pubmed]
Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenz. Borroto-Esoda, K., Waters, J.M., Bae, A.S., Harris, J.L., Hinkle, J.E., Quinn, J.B., Rousseau, F.S. AIDS Res. Hum. Retroviruses (2007) [Pubmed]
In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine. Borroto-Esoda, K., Vela, J.E., Myrick, F., Ray, A.S., Miller, M.D. Antivir. Ther. (Lond.) (2006) [Pubmed]
In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1. Borroto-Esoda, K., Myrick, F., Feng, J., Jeffrey, J., Furman, P. Antimicrob. Agents Chemother. (2004) [Pubmed]